{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:36:59Z","timestamp":1740166619111,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Subclinical hypothyroidism is a thyroid disorder diagnosed from the laboratory blood test results of otherwise asymptomatic patients. It has been associated with poor cardiovascular outcomes, mortality and progression to overt thyroid hormone deficiency. Current guidelines on the management of subclinical hypothyroidism differ because of conflicting evidence on long-term treatment benefits. Even though there are several existing systematic reviews on its clinical outcomes, no definitive conclusion has been reached yet. As such, a new synthesis could help provide more insight and consensus on this topic. To this purpose, this umbrella review will evaluate and synthesise current evidence on the long-term clinical outcomes of the different management strategies for subclinical hypothyroidism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a protocol for an umbrella review on the management strategies for subclinical hypothyroidism. We will conduct literature searches in multiple electronic databases (from inception onwards), namely MEDLINE, EMBASE, Scopus, Web of Science, Cochrane Database of Systematic Reviews, JBI Evidence Synthesis, Epistemonikos database, PDQ Evidence and the PROSPERO register. There will be no restriction on the date or language of publication. Additional material will be identified through grey literature searches and citation chaining. Review inclusion criteria will be patients with subclinical hypothyroidism, receiving treatment or monitoring, no restrictions on the comparators used and with cardiovascular events, frailty fractures, quality of life and all-cause mortality as primary outcomes of interest. Two reviewers will independently screen all citations, full-text articles and abstract data on a pre-piloted form in duplicate. Methodological quality (or bias) of included studies will be appraised using AMSTAR-2. Any conflicts that arise will be resolved through discussion or involving a third reviewer. A narrative synthesis will be provided with information presented in the main text and tables to summarise and explain the characteristics and findings of the included reviews. Even so, it is not expected that a meta-analysis will be performed due to review variability. Study limitations and methodological quality assessments will also be reported to provide context for the overall summary of evidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This review will provide a comprehensive summary of the effects of the pharmacological and non-pharmacological management of subclinical hypothyroidism on specific long-term clinical outcomes. It is anticipated that the findings of this umbrella review will aid in the development of consensus-based clinical recommendations for subclinical hypothyroidism, as well as highlight areas for future research. Review findings will be disseminated primarily through peer-reviewed publications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>PROSPERO CRD42021235172<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-021-01842-y","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T20:41:25Z","timestamp":1635799285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management strategies for patients with subclinical hypothyroidism: a protocol for an umbrella review"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1417-1260","authenticated-orcid":false,"given":"Brenda S.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaya","family":"Azcoaga-Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utkarsh","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"McCowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"1842_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/2042018815616543","volume":"7","author":"Z Javed","year":"2016","unstructured":"Javed Z, Sathyapalan T. Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits. Therapeutic Adv Endocrinol Metab. 2016;7:12\u201323.","journal-title":"Therapeutic Adv Endocrinol Metab"},{"key":"1842_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jama.291.2.228","volume":"291","author":"MI Surks","year":"2004","unstructured":"Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Jama. 2004;291:228\u201338.","journal-title":"Jama."},{"key":"1842_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1365-2265.2005.02246.x","volume":"62","author":"S Chubb","year":"2005","unstructured":"Chubb S, Davis W, Inman Z, Davis T. Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin Endocrinol. 2005;62:480\u20136.","journal-title":"Clin Endocrinol"},{"key":"1842_CR4","first-page":"430","volume":"114","author":"J Sch\u00fcbel","year":"2017","unstructured":"Sch\u00fcbel J, Feldkamp J, Bergmann A, Drossard W, Voigt K. Latent hypothyroidism in adults. Deutsches \u00c4rzteblatt International. 2017;114:430.","journal-title":"Deutsches \u00c4rzteblatt International."},{"key":"1842_CR5","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/jama.2010.1361","volume":"304","author":"N Rodondi","year":"2010","unstructured":"Rodondi N, Den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. Jama. 2010;304:1365\u201374.","journal-title":"Jama."},{"key":"1842_CR6","first-page":"811","volume":"172","author":"S Razvi","year":"2012","unstructured":"Razvi S, Weaver JU, Butler TJ, Pearce SH. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Internal Med. 2012;172:811\u20137.","journal-title":"Arch Internal Med"},{"key":"1842_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1210\/jc.2009-1625","volume":"95","author":"RW Flynn","year":"2010","unstructured":"Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010;95:186\u201393.","journal-title":"J Clin Endocrinol Metab"},{"key":"1842_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0002-9343(02)01022-7","volume":"112","author":"WM Kong","year":"2002","unstructured":"Kong WM, Sheikh MH, Lumb PJ, Freedman DB, Crook M, Dor\u00e9 CJ, et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med. 2002;112:348\u201354.","journal-title":"Am J Med."},{"key":"1842_CR9","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","volume":"379","author":"DS Cooper","year":"2012","unstructured":"Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379:1142\u201354.","journal-title":"Lancet."},{"key":"1842_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","volume":"29","author":"B Biondi","year":"2008","unstructured":"Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews. 2008;29:76\u2013131.","journal-title":"Endocrine Reviews."},{"key":"1842_CR11","doi-asserted-by":"crossref","unstructured":"Vasileiou M, Gilbert J, Fishburn S, Boelaert K. Thyroid disease assessment and management: summary of NICE guidance. BMJ. 2020;368:m41.","DOI":"10.1136\/bmj.m41"},{"key":"1842_CR12","volume-title":"Thyroid disease: assessment and management","author":"UK National Guideline Centre","year":"2019","unstructured":"UK National Guideline Centre. Thyroid disease: assessment and management. 2019."},{"key":"1842_CR13","doi-asserted-by":"crossref","unstructured":"Bekkering G, Agoritsas T, Lytvyn L, Heen A, Feller M, Moutzouri E, et al. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ. 2019;365:l2006.","DOI":"10.1136\/bmj.l2006"},{"key":"1842_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.2018.13770","volume":"320","author":"M Feller","year":"2018","unstructured":"Feller M, Snel M, Moutzouri E, Bauer DC, de Montmollin M, Aujesky D, et al. Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis. Jama. 2018;320:1349\u201359.","journal-title":"Jama."},{"key":"1842_CR15","first-page":"w14058","volume":"144","author":"C Baumgartner","year":"2014","unstructured":"Baumgartner C, Blum MR, Rodondi N. Subclinical hypothyroidism: summary of evidence in 2014. Swiss Med Weekly. 2014;144:w14058.","journal-title":"Swiss Med Weekly."},{"key":"1842_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.beem.2011.12.004","volume":"26","author":"B Biondi","year":"2012","unstructured":"Biondi B. Natural history, diagnosis and management of subclinical thyroid dysfunction. Best Pract Res Clin Endocrinol Metab. 2012;26:431\u201346.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1842_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13499","volume":"74","author":"SG Chrysant","year":"2020","unstructured":"Chrysant SG. The current debate over treatment of subclinical hypothyroidism to prevent cardiovascular complications. Int J Clin Practice. 2020;74:e13499.","journal-title":"Int J Clin Practice."},{"key":"1842_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/ebmental-2018-300014","volume":"21","author":"P Fusar-Poli","year":"2018","unstructured":"Fusar-Poli P, Radua J. Ten simple rules for conducting umbrella reviews. Evidence-based Mental Health. 2018;21:95\u2013100.","journal-title":"Evidence-based Mental Health."},{"key":"1842_CR19","unstructured":"Centre for Reviews and Dissemination. PROSPERO International prospective register of systematic reviews: University of York; 2021 [cited 2021 15\/01]. Available from: https:\/\/www.crd.york.ac.uk\/prospero\/."},{"key":"1842_CR20","doi-asserted-by":"crossref","unstructured":"Aromataris E, Fernandez R, Godfrey C, Holly C, Khalil H, Tungpunkom P. Chapter 10: Umbrella reviews. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis: JBI; 2020.","DOI":"10.46658\/JBIMES-20-11"},{"key":"1842_CR21","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015: elaboration and explanation. Brit Med J. 2015;349:g7647. https:\/\/doi.org\/10.1136\/bmj.g7647.","journal-title":"Brit Med J"},{"key":"1842_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Systematic Reviews. 2015;4:1. https:\/\/doi.org\/10.1186\/2046-4053-4-1.","journal-title":"Systematic Reviews."},{"key":"1842_CR23","unstructured":"The EndNote Team. EndNote. EndNote X9 ed. Philadelphia: Clarivate; 2013."},{"key":"1842_CR24","unstructured":"Veritas Health Innovation. Covidence systematic review software Melbourne, Australia2013. Available from: www.covidence.org."},{"key":"1842_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-7-10","volume":"7","author":"BJ Shea","year":"2007","unstructured":"Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.","journal-title":"BMC Med Res Methodol"},{"key":"1842_CR26","doi-asserted-by":"crossref","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.","DOI":"10.1136\/bmj.j4008"},{"key":"1842_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jclinepi.2019.05.028","volume":"114","author":"RC Lorenz","year":"2019","unstructured":"Lorenz RC, Matthias K, Pieper D, Wegewitz U, Morche J, Nocon M, et al. A psychometric study found AMSTAR 2 to be a valid and moderately reliable appraisal tool. J Clin Epidemiol. 2019;114:133\u201340.","journal-title":"J Clin Epidemiol"},{"key":"1842_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-11-15","volume":"11","author":"V Smith","year":"2011","unstructured":"Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011;11:1\u20136.","journal-title":"BMC Med Res Methodol"},{"key":"1842_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383\u201394.","journal-title":"J Clin Epidemiol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01842-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-021-01842-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01842-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T20:43:21Z","timestamp":1635799401000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-021-01842-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1186\/s13643-021-01842-y","relation":{},"ISSN":["2046-4053"],"issn-type":[{"type":"electronic","value":"2046-4053"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"assertion":[{"value":"12 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}